<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Segoe UI";
panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Melior;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma",sans-serif;}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Segoe UI",sans-serif;}
p.msochpdefault, li.msochpdefault, div.msochpdefault
{mso-style-name:msochpdefault;
margin:0in;
margin-bottom:.0001pt;
font-size:10.0pt;
font-family:"Times New Roman",serif;}
span.emailstyle18
{mso-style-name:emailstyle18;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.balloontextchar0
{mso-style-name:balloontextchar;
font-family:"Tahoma",sans-serif;}
span.emailstyle22
{mso-style-name:emailstyle22;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle24
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif">I’m not speaking to the effectiveness of any product to degrade drugs, however, I think it’s important to remember that products sold to an ultimate
user to destroy her OWN medications at home are not regulated under the DEA rule; just like vinegar or soft drinks which can also be bought by the consumer and used to destroy their drugs before putting into the trash. So I’m not sure why DEA is being referenced
in the attachment. These products really have nothing to do with the rule unless they are being used by a registrant to destroy drugs. As the rule summary states,
<i>“</i></span><i><span style="font-size:11.0pt;font-family:"Calibri",sans-serif">These regulations will implement the Secure and Responsible Drug Disposal Act of 2010 by
<u>expanding the options available to collect controlled substances from ultimate users for the purpose of disposal</u>, including:
<u>Take-back events, mail-back programs, and collection receptacle locations</u>.”</span></i><span style="font-size:11.0pt;font-family:"Calibri",sans-serif"> The purpose was to give ultimate users (and LTC) options to “hand off” the drugs for destruction other
than putting them the trash or sewer. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif">Thanks,<o:p></o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif">Jan Harris, MPH<o:p></o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif">Director, EHS<o:p></o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif">Sharps Compliance<o:p></o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif"><a href="mailto:jharris@sharpsinc.com">jharris@sharpsinc.com</a><o:p></o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif">713-927-9956<o:p></o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><i><span style="font-size:9.0pt;font-family:Melior"><o:p> </o:p></span></i></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:9.0pt;font-family:Melior"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:#1F497D"><o:p> </o:p></span></p>
<div></div>
</div>
<br>
<font style="font-family:Calibri;font-size:11pt;color:Black;">Jan Harris</font><a style="FONT-SIZE: 11pt; FONT-FAMILY: Calibri; COLOR: #808080"><font style="font-family:Calibri;font-size:11pt;color:Gray;"> |
</font><font style="font-family:Calibri;font-size:11pt;color:Gray;">Director, Environmental Health & Safety</font></a><font face="Calibri">
</font>
<p></p>
<p><a style="FONT-SIZE: 11pt; FONT-FAMILY: Calibri; COLOR: #000000"><font style="font-family:Calibri;font-size:11pt;color:#000000;">Sharps Compliance, Inc.</font></a><br>
<font style="font-family:Calibri;font-size:11pt;color:Gray;">d- </font><font style="font-family:Calibri;font-size:11pt;color:Gray;">713-927-9956</font><br>
<br>
<a style="FONT-SIZE: 11pt; TEXT-DECORATION: none; FONT-FAMILY: Calibri; COLOR: #808080" href="mailto:jharris@sharpsinc.com">jharris@sharpsinc.com<font style="font-family:Calibri;font-size:11pt;color:#000000;"> |
</font></a><a style="FONT-SIZE: 11pt; TEXT-DECORATION: none; FONT-FAMILY: Calibri; COLOR: #808080" href="http://www.sharpsinc.com">http://www.sharpsinc.com</a>
</p>
<p></p>
<div class="WordSection1">
<div></div>
</div>
<p></p>
<p></p>
<p></p>
<div class="WordSection1">
<div>
<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b><span style="font-size:11.0pt;font-family:"Calibri",sans-serif">From:</span></b><span style="font-size:11.0pt;font-family:"Calibri",sans-serif"> pharmwaste-bounces@lists.dep.state.fl.us [mailto:pharmwaste-bounces@lists.dep.state.fl.us]
<b>On Behalf Of </b>Ed Gottlieb<br>
<b>Sent:</b> Monday, April 13, 2015 10:31 AM<br>
<b>To:</b> pharmwaste@lists.dep.state.fl.us<br>
<b>Subject:</b> [Pharmwaste] Does activated carbon treatment meet "non-retrievable" standard?<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black">Hi All,<br>
<br>
In response to inquires regarding destruction products, today I received the attached letter. It has URLs to a number of studies that show activated carbon in general or the medsaway product in particular work as advertized, given enough hours.
<br>
<br>
I noted they were written by one of the companies principles or the study was funded by the manufacturer. Two were presented at conferences. I wrote back to ask if any have been published in a peer reviewed journal.
<br>
<br>
Phoned a large activated carbon supplier (buyactivatedcharcoal.com) and they were quite convincing, that once pharmaceuticals bind to the activated carbon, they can't be extracted. The knowledgeable person I spoke with will follow-up with their expert and
send me any published studies they can find that would support this conclusion. <o:p>
</o:p></span></p>
<div>
<p class="MsoNormal" style="margin-bottom:12.0pt"><span style="font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black">Will pass on what I receive.<o:p></o:p></span></p>
<div>
<div>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black">Ed Gottlieb<br>
Chair, Coalition for Safe Medication Disposal<o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black">Industrial Pretreatment Coordinator<o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black">Ithaca Area Wastewater Treatment Facility<br>
525 3</span><sup><span style="color:black">rd</span></sup><span style="font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black"> Street<o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black">Ithaca, NY 14850<o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black">(607) 273-8381<o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black">fax: (607) 273-8433<o:p></o:p></span></p>
</div>
</div>
</div>
</div>
</div>
</div>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
<div style="FONT-SIZE: 11pt"><span style="FONT-SIZE: 11pt; FONT-WEIGHT: bold"><font style="COLOR: #000000" face="Calibri">[COLLECT/PROTECT/RESPECT]</font></span></div>
<div style="FONT-SIZE: 11pt"><span style="FONT-SIZE: 11pt; COLOR: #000000"><font face="Calibri"></font></span></div>
<div style="FONT-SIZE: 11pt"><span style="FONT-SIZE: 11pt; COLOR: #99cc33"><font face="Calibri">Sharps Compliance repurposed an estimated 758 million syringes into a material powering over 250 homes per year and collected 320,000 pounds of unused medications,
reducing potential harm to citizens and the earth.</font></span></div>
<div style="FONT-SIZE: 10pt"><font face="Calibri"><br>
</font></div>
<div><span style="FONT-SIZE: 10pt; COLOR: #808080"><font face="Calibri">PRIVACY NOTICE: This information is intended only for the use of the individual or entity to which it is addressed and may contain information that is privileged, confidential or exempt
from disclosure under applicable federal or state law. If the reader of this message is not the intended recipient or the employee or agent responsible for delivering the message to the intended recipient, you are hereby notified that any dissemination, distribution
or copying of communication is strictly prohibited. If you have received this communication in error, contact the sender and delete the material from any computer.</font></span></div>
<div style="FONT-SIZE: 10pt"><br>
</div>
</body>
</html>